Vanda Pharmaceuticals
VNDA
#7413
Rank
โ‚ฌ0.37 B
Marketcap
6,35ย โ‚ฌ
Share price
-3.08%
Change (1 day)
51.02%
Change (1 year)

Revenue for Vanda Pharmaceuticals (VNDA)

Revenue in 2025 (TTM): โ‚ฌ0.18 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.17 Billion. In 2024 the company made a revenue of โ‚ฌ0.19 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ0.17 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vanda Pharmaceuticals from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.18 B-0.57%
2024 โ‚ฌ0.19 B9.61%
2023 โ‚ฌ0.17 B-26.52%
2022 โ‚ฌ0.23 B-0.04%
2021 โ‚ฌ0.23 B17.59%
2020 โ‚ฌ0.20 B-0.51%
2019 โ‚ฌ0.20 B20.14%
2018 โ‚ฌ0.16 B22.69%
2017 โ‚ฌ0.13 B-0.89%
2016 โ‚ฌ0.13 B38.08%
2015 โ‚ฌ0.10 B143.78%
2014 โ‚ฌ41.23 M68.11%
2013 โ‚ฌ24.53 M-0.85%
2012 โ‚ฌ24.74 M2.75%
2011 โ‚ฌ24.07 M-10.31%
2010 โ‚ฌ26.84 M745.76%
2009 โ‚ฌ3.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ77.62 B 43,351.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ47.48 B 26,481.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ52.89 B 29,505.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ50.05 B 27,918.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ54.11 B 30,188.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ40.46 B 22,549.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA